PIERIS PHARMACEUTICALS, INC. (PIRS)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading PIERIS PHARMACEUTICALS, INC. chart...

About the Company

We do not have any company description for PIERIS PHARMACEUTICALS, INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

140

Exchange

Nasdaq

$42M

Total Revenue

140

Employees

$15M

Market Capitalization

-4.40

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PIRS News

Pieris Pharmaceuticals Inc.

4d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential

23d ago, source: Fort Worth Star-Telegram

BOSTON,MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential ...

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential

23d ago, source: Finanznachrichten

Pieris Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und FNRD-2.627.0 ...

Pieris Pharmaceuticals Inc PIRS

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Pieris Pharmaceuticals Inc PIRS

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pieris Pharmaceuticals, Inc. (PIRS)

23d ago, source: Yahoo Finance

BOSTON, MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...